GlassScriptPhysician profile
Mccall R Walker
NPI 1457705501
$19,279.45
in general payments reported to CMS, 2019-2025
31 companies · $8,776 in 2025
The $8,776 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $139 · 2021: $42.48 · 2022: $892 · 2023: $1,088 · 2024: $8,114 · 2025: $8,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,083 · Food and Beverage: $6,967 · Consulting Fee: $1,500 · Travel and Lodging: $219 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,083.33 |
| Food and Beverage | $6,966.63 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $218.95 |
| Education | $209.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,925.56 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Bard Peripheral Vascular, INC. | $1,633.75 | 2022-2024 | |
| Abbott Laboratories | $1,230.90 | 2019-2025 | Esprit, Ensite, Cardiomems |
| Philips North America LLC | $1,033.28 | 2022-2025 | (Az7) Lasers, Labosys, (P84) Igt Devices Systems |
| Cardiva Medical, INC. | $503.13 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Medtronic, INC. | $409.07 | 2024-2025 | Venaseal, Symplicity G3, Hawkone |
| Surmodics, INC. | $406.39 | 2024-2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Inari Medical, INC. | $350.61 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $260.01 | 2024-2025 | Wegovy, Ozempic |
| Penumbra, INC. | $248.44 | 2024-2025 | Indigo System |
| Biotronik INC. | $239.00 | 2022-2023 | Pulsar-18 T3 |
| E.R. Squibb & Sons, L.L.C. | $233.67 | 2024-2025 | Camzyos, Eliquis |
| Imperative Care, INC | $192.13 | 2024-2025 | Symphony Catheter |
| Boston Scientific Corporation | $181.60 | 2020-2021 | |
| Abiomed | $163.07 | 2023 | Impella |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $154.21 | 2024-2025 | |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Tactile Systems Technology INC | $144.81 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Becton, Dickinson and Company | $126.88 | 2023-2024 | Venclose Maven Catheter |
| Shockwave Medical, INC | $123.92 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $107.04 | 2023-2025 | Repatha, Repatha |
| W. L. Gore & Associates, INC. | $101.46 | 2023 | Gore Cardioform Septal Occluder |
| Kestra Medical Technology Services, INC. | $65.21 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $64.49 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.87 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $37.48 | 2023-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $35.85 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $32.67 | 2024 | |
| Itamar Medical INC | $30.95 | 2024 | Watchpatone |
| Alnylam Pharmaceuticals INC. | $24.38 | 2025 | Onpattro |
| Terumo Medical Corporation | $20.62 | 2024 | Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mccall Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.